The role of compliance as a cause of instability in oral anticoagulant therapy

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 893-900

  Van Der Meer, Felix J M ^a   Briët, Ernest ^a   Vandenbroucke, Jan P ^a   Šrámek, Dagmar I ^a   Versluijs, Myrthe H P M ^a   Rosendaal, Frits R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Compliance; Instability; Oral anticoagulant therapy; Phenprocoumon; Thrombosis service

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT PLANNING;

EID: 0030798388     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-3544.x     Document Type: Article

References (25)

1. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group (1994) Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet, 343, 499-503.
2. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Archives of Internal Medicine, 154, 1449-1457.
3. Cannegieter, S.C., Rosendual, F.R., Bollen, W.L.E.M. & Briët, E. (1996) Risk factors for ischemic and hemorrhagic stroke in the anticoagulant treatment of patients with mechanical heart valve prostheses. In: Optimal oral anticoagulant therapy in patients with mechanical heart valves (Thesis).
4. Cannegieter, S.C., Rosendaal, F.R., Wintzen, A.R., Van der Meer, F.J.M., Vandenbroucke, J.P. & Briët, E. (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. New England Journal of Medicine, 333, 11-17.
5. Cramer, J.A., Mattson, R.H., Prevey, M.L., Scheyer, R.D. & Ouelette, V.L. (1989) How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 261, 3273-3277.
6. EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet, 342, 1255-1262.
7. Fihn, S.D., Callahan, C.M., Martin, D.C., McDonell, M.B., Henikoff, J.G. & White, R.H. (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. Annals of Internal Medicine, 124, 970-979.
8. Fihn, S.D., McDonell, M. Martin, D., Henikoff, J., Vermes, D., Kent, D. & White, R.H. (1993) Risk factors for complications of chronic anticoagulation. Annals of Internal Medicine, 118, 511-520.
9. Fitzmaurice, D.A., Hobbs, F.D.R. & Murray, J.A. (1996) Monitoring oral anticoagulation in primary care: quality assurance and computerised decision support will help to minimise inconsistensies. British Medical Journal, 312, 1431-1432.
10. Harder, S. & Thürmann, P. (1996) Clinically important drug interactions with anticoagulants: an update. Clinical Pharmacokinetics, 30, 416-444.
11. Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A.G.G., McLouglin, D., Dodd, P., Thomas, M., Raskob, G. & Ockelford, P. (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. New England Journal of Medicine, 307, 1676-1681.
12. Hylek, E.M., Skates, S.J., Sheehan, M.A. & Singer, D.E. (1996) An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New England Journal of Medicine, 335, 540-546.
13. Kumar, S., Haigh, J.R.M., Rhodes, L.E., Peaker, S., Davies, J.A., Roberts, B.E. & Feely, M.P. (1989) Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thrombosis and Haemostasis, 62, 729-732.
14. Lassen, J.F., Brandslund, I. & Antonsen, S. (1995) International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clinical Chemistry, 41, 444-447.
15. O'Reilly, R.A., Aggeler, P.M., Silvija Hoag, M., Leong, L.S. & Kropatkin, M.L. (1964) Hereditary transmission of exceptional resistance to coumarin anticoagulant drugs. New England Journal of Medicine, 271, 809-815.
16. Paterson, P.E. & Kwaan, H.C. (1986) Current concepts of warfarin therapy. Archives of Internal Medicine, 146, 581-584.
17. Pullar, T., Birtwell, A.J., Wiles, P.G., Hay, A. & Feely, M.P. (1988) Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clinical and Pharmacological Therapeutics, 44, 540-545.
18. Rosendaal, F.R. (1996) The Scylla and Charybdis of oral anticoagulant treatment. New England Journal of Medicine, 335, 587-589.
19. Schulman, S. & Lockner, D. (1985) Relationship between thromboembolic complications and intensity of treatment during long-term prophylaxis with oral anticoagulants following DVT. Thrombosis and Haemostasis, 53, 137-140.
20. Smith, P., Arnesen, H. & Holme, I. (1990) The effect of warfarin on mortality and reinfarction after myocardial infarction. New England Journal of Medicine, 323, 147-152.
21. The European Atrial Fibrillation Trial Study Group (1995) Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. New England Journal of Medicine, 333, 5-10.
22. Urquhart, J. (1994) Role of patient compliance in clinical pharmacokinetics: a review of recent research. Clinical Pharmacokinetics, 27, 202-215.
23. Van den Besselaar, A.M.H.P., Van der Meer, F.J.M. & Gerrits-Drabbe, C.W. (1988) Therapeutic control of oral anticoagulant treatment in the Netherlands. American Journal of Clinical Pathology, 90, 685-690.
24. Van der Meer, F.J.M., Rosendaal, F.R., Vandenbroucke, J.P. & Briët, E. (1993) Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Archives of Internal Medicine, 153, 1557-1562.
25. Van der Meer, F.J.M., Rosendaal, F.R., Vandenbroucke, J.P. & Briët, E. (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis and Haemostasis, 76, 12-16.